Companies /Healthcare

Palatin Technologies Inc

NYSE ARCA: PTN Biotechnology
$10.73
▼ $0.21 (−1.92%) today
Markets open · 10:51am ET
Today · % change

Fundamentals

Market Cap
$19.5M
P/E Ratio
121.6
Profit Margin
-48.5%
Revenue (TTM)
$12.9M
EPS (TTM)
$0.09
52-Week Range
$6 – $31
Street Target
$53.50

About PTN

Palatin Technologies, Inc., a specialty biopharmaceutical company, develops targeted receptor-specific therapies for the treatment of various diseases in the United States. The company is headquartered in Cranbury, New Jersey.

PTN Coverage